Showing results (41-50 of 127) with videos related to
Sort By:
Pageof 13
Clinical Rheumatology|October 23, 2019
Assessing disease severity in bio-naïve patients with RA on treatment with csDMARDs: insights from the Corrona RegistryLeslie R Harrold, Pankaj A Patel, Jenny Griffith, et al.The American Journal of Medicine|January 28, 2010
The dynamics of chronic gout treatment: medication gaps and return to therapyLeslie R Harrold, Susan E Andrade, Becky Briesacher, et al.Clinical Rheumatology|July 19, 2017
Impact of rituximab on patient-reported outcomes in patients with rheumatoid arthritis from the US Corrona RegistryLeslie R Harrold, Ani John, Jennie Best, et al.Arthritis Care & Research|February 22, 2011
Greater likelihood of remission in rheumatoid arthritis patients treated earlier in the disease course: results from the Consortium of Rheumatology Researchers of North America registryDaniel E Furst, Aileen L Pangan, Leslie R Harrold, et al.Seminars in Arthritis and Rheumatism|August 13, 2023
Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic reviewJeffrey A Sparks, Leslie R Harrold, Teresa A Simon, et al.The Journal of Rheumatology|January 17, 2013
Cost-related medication nonadherence in older patients with rheumatoid arthritisLeslie R Harrold, Becky A Briesacher, Dan Peterson, et al.Pharmacoepidemiology and Drug Safety|May 3, 2013
Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009Maryam M Asgari, Jashin J Wu, Joel M Gelfand, et al.Advances in Rheumatology (London, England)|January 19, 2024
Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positiveLeslie R Harrold, Keith Wittstock, Sheila Kelly, et al.Arthritis Care & Research|April 26, 2016
Risk of Infection Associated With Subsequent Biologic Agent Use After Rituximab: Results From a National Rheumatoid Arthritis Patient RegistryLeslie R Harrold, George W Reed, Chitra Karki, et al.Arthritis Research & Therapy|December 2, 2016
Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registryLeslie R Harrold, George W Reed, Daniel H Solomon, et al.Pageof 13